These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Clinical symptoms and duration of anamnesis in patients with hypophyseal tumors]. Dietel P; Heberling HJ; Lohmann D; Brachmann J Z Gesamte Inn Med; 1989 May; 44(10):293-6. PubMed ID: 2763595 [TBL] [Abstract][Full Text] [Related]
13. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests. Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727 [No Abstract] [Full Text] [Related]
14. Cushing's syndrome produced by bronchial carcinoid associated with hypophyseal adenoma. Morán C; Flores M; Loyo M; Rivas A; Zárate A Arch Invest Med (Mex); 1985; 16(1):111-8. PubMed ID: 4015294 [No Abstract] [Full Text] [Related]
15. [Progress in the hormonal detection of pituitary prolactin adenoma]. De Gennes JL; Turpin G; Heshmati HM; Carayon A Ann Med Interne (Paris); 1982; 133(1):12-6. PubMed ID: 7065584 [No Abstract] [Full Text] [Related]
16. The management of pituitary adenomas: the MGH experience. Swearingen B; Barker FG; Zervas NT Clin Neurosurg; 1999; 45():48-56. PubMed ID: 10461502 [No Abstract] [Full Text] [Related]
18. Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome. D'Agata R; Aliffi A; Vicari E; Volpicelli D; Mongioì A; Gulizia S Horm Res; 1981; 14(3):148-54. PubMed ID: 7286887 [TBL] [Abstract][Full Text] [Related]
19. Use of thyrotropin-releasing hormone in clinical medicine. Hershman JM Med Clin North Am; 1978 Mar; 62(2):313-25. PubMed ID: 417224 [No Abstract] [Full Text] [Related]
20. Nomifensine: diagnostic test in hyperprolactinemic states. Müller EE; Genazzani AR; Murru S J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]